How to pronounce it: VEXAS - vex-us
VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a rare autoinflammatory disorder that was first identified in 2020. This syndrome is characterized by a combination of symptoms, including recurrent fevers, blood abnormalities, and inflammatory skin lesions. The term "VEXAS" reflects some of the key features of the syndrome.
Here's a breakdown of the components of the term "VEXAS":
Flares: Periods of worsening symptoms are called flares. A flare can last for hours, days, weeks, or months.
Physical Activity: Condition improves with activity and exercise and worsens with rest.
Comorbidities: When inflammation is left uncontrolled due to lack of proper treatment, comorbidities can develop. 70% of patients with chronic, lifelong disease will develop comorbidities, including dual or triple diagnoses.
Family History:
Autoimmune diseases often run in families, indicating a potential genetic predisposition where that gene can cause disease. Autoinflammatory diseases can occur multiple times in a family, but is based off of genetic mutation. It is not a gene that causes the disease— but a mutation on the gene that can cause the disease which can then be passed on to the next generation.
Fatigue: Severe fatigue or exhaustion that may not be helped by caffeine/stimulants and can happen even after a long period of rest.
Cognitive Dysfunction: Brain fog or periods of time where thinking gets clouded and it becomes difficult to concentrate.
Flu-like symptoms: Without having the flu- nausea, muscle weakness, and general malaise.
Fever: Typically low grade in autoimmune (with exception of juvenile idiopathic arthritis) and higher grade in autoinflammatory (% strongly varies per disease).
Reference: Early Symptoms of AiArthritis Study, AiArthritis, 2019.
Stiffness: Severe stiffness in one or more joints, especially in the morning or after sitting for long periods of time.
Joint Pain: Episodes of joint pain that may last for hours, days, or even weeks, that can appear and disappear suddenly. Often described as “jumping pain” into different locations.
Typically the joint pain will coincide with one or more “Auto” symptoms and start and stop suddenly - for no apparent reason (which is called a "flare"). Some people will experience all of the above symptoms, others only a few.
If you have any of the arthritis features, and at least one of the “Auto” features, please consult your physician about a referral to a specialist.
There’s no single test that can confirm a VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome diagnosis, so rheumatologists, geneticists, and other specialists use a combination of clinical evaluation, genetic testing, and laboratory assessments. Due to the rarity and complexity of VEXAS, a multidisciplinary approach is often required.
Key components of diagnosis include:
Given the recent discovery of VEXAS syndrome, genetic testing for UBA1 mutations is crucial for confirming the diagnosis and typically requires expert consultation. Accurate diagnosis is essential for managing and treating this rare condition.
Since symptoms are intermittent, it is important to have tests and imaging done during an attack or flare to capture the signs of inflammation. If that’s not possible, documenting symptoms through photos and symptom logs can be essential for aiding diagnosis.
Treatments are tailored to each individual's disease, but visit our Treatment Options page to learn more about the different types of treatments that are used for VEXAS Syndrome.
We need YOUR advice! Fill out this form to give peer advice to those with your disease.
VEXAS syndrome was only identified in 2020, named for its key features: Vacuoles, E1 enzyme, X-linked, Autoinflammatory, and Somatic mutations. It was discovered through genetic research when scientists identified a mutation in the UBA1 gene causing an autoinflammatory syndrome primarily affecting men later in life.
In an effort to ensure this page has the most accurate and up-to-date information, this page is currently awaiting medical review. Some information is subject to change.
Page Last Updated: 10/31/2024
International Foundation for AiArthritis
6605 Nottingham Ave.
St. Louis, MO 63109-2661
Tax ID: 27-1214308
Copyright 2024. All rights reserved. Information on this site is intended for informational purposes only Our foundation does not engage in the practice of medicine. Please consult a physician to obtain personal healthcare and treatment options. 501(c) 3 Nonprofit Tax ID: 27-1214308.